🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The latest in cost-effectiveness analyses... It will be a great discussion at this panel at the upcoming Boston symposium on Oct 26. Register: In person: tinyurl.com/5x3ey26t Virtual: tinyurl.com/yckdh8nr Anirban Basu Mel Whittington Society for Medical Decision Making (SMDM) The Centre for Health Economics

Join us in Las Vegas for #AMCPNexus 2024 for 2 educational sessions by James Chambers and Molly Beinfeld's presentation of Fariel LaMountain's Platinum Ribbon-winning research on adalimumab product coverage. A full list of CEVR participation can be found here: cevr.tuftsmedicalcenter.org/news/spec-part…

We are pleased to announce that Brian Reid, a nationally-recognized expert in prescription drug policy and communications, has joined CEVR as a Senior Fellow. More here: tinyurl.com/3639u5nv #heor

I am super-pumped at the prospect of collaborating with Peter and his team. We're living in a time of value, and I can't wait to contribute to the conversation.

What does the future hold for CEA? Hear from experts Davene R. Wright, PhD, Fernando Alarid-Escudero, @nlcrossnohere, and David Kim during Panel 5 at 10/26 Tufts-CEVR / Duke Margolis event. Register now: In-person: eventbrite.com/e/tufts-cevrdu… Webinar: wellforce.zoom.us/webinar/regist…

We are thrilled to announce that pioneering #CEA researcher Milton C. Weinstein has joined Panel 2 at the 10/26 Tufts-CEVR / Duke Margolis symposium. Register now! In person: eventbrite.com/e/tufts-cevrdu… Webinar: wellforce.zoom.us/webinar/regist…

Excited to announce that Milton Weinstein will join the "legends" panel at the 10/26 CEVR-Duke-Margolis hosted symposium in Boston, "Celebrating Cost-Effectiveness Analysis." Moderated by Ankur Pandya Register in person or online: tinyurl.com/v4zd34mp Society for Medical Decision Making (SMDM)

The final agenda for the 10/26 symposium in Boston, "Celebrating CEA," is now available. Panelists include: Anirban Basu, Rena Conti, Emond, Garrison, Lakdawalla, Phelps, Weinstein, etc. Register in person or online: tinyurl.com/2ab38f9p CEVR Duke-Margolis Society for Medical Decision Making (SMDM)

Drug value assessments are important, but economists shouldn't neglect assessment of health services and procedures. Hear perspectives from CEVR's Peter Neumann, Christopher Roebuck, and EBRI's Paul Fronstin during Oct. 31 public webinar. Register now: wellforce.zoom.us/webinar/regist…

Pleased to give Grand Rounds today at Tufts Medical Center!

I’ll also be presenting at the Cost-Effectiveness Thresholds Used in Cost-Per-QALY Studies on Tuesday at 3:50PM — Don’t miss it! 🙌 Grateful for the support from ⁦Ashley Leech⁩ ⁦David D. Kim (김대호)⁩ ⁦Peter Neumann⁩ #SMDM24 #MDMTwitter

Which #HEOR superhero are you? Looking forward to meeting many of my HEOR heroes at tomorrow’s symposium on cost-effectiveness analysis #CelebrateCEA CEVR

✨💡Illuminators of cost-effectiveness analysis in health and medicine 💡✨ So inspired by the pioneers of #CEA who've shaped our field of study! CEVR Peter Neumann Ankur Pandya Patricia Synnott #CelebrateCEA

Excited to have #SMDM24 meeting in Boston this year! Amber Barnato and Jag Chhatwal kicking things off. Society for Medical Decision Making (SMDM) CEVR

Thank you, Kathryn A Phillips PhD !

Me presenting Society for Medical Decision Making (SMDM) ! So happy to work with Ashley Leech David D. Kim (김대호) Peter Neumann 🙌 It was wonderful to share our findings on CEA thresholds in cost-per-QALY studies worldwide based on CEVR CEA registry at #SMDM24

A cost-effective treatment for #Alzheimers would improve US population health and health equity. Read the new distributional CEA by CEVR and Genentech for data-driven insights on policies to further mitigate disparities. jamanetwork.com/journals/jaman…

Small molecules and biologics are eligible for #IRA price negotiation 9 vs 13 years after approval. New CEVR research shows small molecules give similar health benefits at lower cost than biologics. Should IRA be reformed to set equivalent timelines? healthaffairs.org/doi/abs/10.137…

The outlook for US payer coverage of specialty drugs in 2005. Register here for our webinar, Dec 4, 3-3:30 ET: tinyurl.com/2pndy8v8 James Chambers Molly Beinfeld NPC Brian Reid #heor #biosimilars CEVR

The best books I read in 2024. My annual list. tinyurl.com/yhs5h87v CEVR Peter B. Bach, MD Stacie Dusetzina Jonathan Eig #books #BooksWorthReading